Pituitary suppressive agents (LHRH) prior authorization
Customize your policy alerts
Sign up for all Geisinger Health Plan policy alerts
Know when Geisinger Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization form and requirements for pituitary suppressive LHRH agents (for indications including central precocious puberty, gender dysphoria, endometriosis, preservation of ovarian function, and specified oral GnRH antagonist combination products); intended for prescribers seeking coverage.
No material clinical or coverage changes in this revision.
Coverage Criteria and Indication-Specific Requirements
Central Precocious Puberty criteria
Covered when ALL applicable indication-specific criteria on the form are met and documentation is submitted:
Document specialist consult, patient sex, age, and onset timing; submit DX code and supporting documentation.
Gender dysphoria criteria
Covered when ALL the following are met for gender dysphoria:
Document provider experience/training and adherence to WPATH or equivalent standards.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.